Stealth BioTherapeutics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Oct 07, 2022: Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
Mar 09, 2022: Stealth BioTherapeutics to Present at Upcoming March Investor Conferences
Feb 22, 2022: Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The publisher's summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Stealth BioTherapeutics Corp (Stealth BioTherapeutics), formerly Stealth Peptides International Inc, a subsidiary of Morningside Venture Investments Ltd, is an early stage biotechnology company. It discovers, develops, and commercializes novel therapies for diseases and disorders associated with mitochondrial dysfunction. The company is investigating elamipretide, a peptide compound that penetrates into cell membranes, for the treatment of primary mitochondrial myopathy, barth syndrome, leber’s hereditary optic neuropathy, duchenne cardiomyopathy, and dry age-related macular degeneration. It is also evaluating SBT-20 for the treatment of neurodegenerative diseases related to mitochondrial dysfunction; and SBT-272, a phase I candidate, for the treatment of rare neurodegenerative diseases. Stealth BioTherapeutics is headquartered in Grand Cayman, Cayman Islands.Stealth BioTherapeutics Corp Key Recent Developments
Oct 07, 2022: Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of ShareholdersOct 07, 2022: Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
Mar 09, 2022: Stealth BioTherapeutics to Present at Upcoming March Investor Conferences
Feb 22, 2022: Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company- Stealth BioTherapeutics Corp - Key Facts
- Stealth BioTherapeutics Corp - Key Employees
- Stealth BioTherapeutics Corp - Key Employee Biographies
- Stealth BioTherapeutics Corp - Major Products and Services
- Stealth BioTherapeutics Corp - History
- Stealth BioTherapeutics Corp - Company Statement
- Stealth BioTherapeutics Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Stealth BioTherapeutics Corp - Business Description
- R&D Overview
- Stealth BioTherapeutics Corp - Corporate Strategy
- Stealth BioTherapeutics Corp - SWOT Analysis
- SWOT Analysis - Overview
- Stealth BioTherapeutics Corp - Strengths
- Stealth BioTherapeutics Corp - Weaknesses
- Stealth BioTherapeutics Corp - Opportunities
- Stealth BioTherapeutics Corp - Threats
- Stealth BioTherapeutics Corp - Key Competitors
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Stealth BioTherapeutics Corp, Recent Deals Summary
- Oct 07, 2022: Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
- Oct 07, 2022: Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
- Mar 09, 2022: Stealth BioTherapeutics to Present at Upcoming March Investor Conferences
- Feb 22, 2022: Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit
- Nov 11, 2021: Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
- Aug 05, 2021: Stealth BioTherapeutics reports second quarter 2021 financial results and recent business highlights
- Jul 30, 2021: Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5
- Jul 07, 2021: Stealth BioTherapeutics joins the rare disease company coalition
- May 28, 2021: Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference
- May 18, 2021: Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Stealth BioTherapeutics Corp, Key Facts
- Stealth BioTherapeutics Corp, Key Employees
- Stealth BioTherapeutics Corp, Key Employee Biographies
- Stealth BioTherapeutics Corp, Major Products and Services
- Stealth BioTherapeutics Corp, History
- Stealth BioTherapeutics Corp, Subsidiaries
- Stealth BioTherapeutics Corp, Key Competitors
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Stealth BioTherapeutics Corp, Recent Deals Summary
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abliva AB
- BioElectron Technology Corp
- Genentech USA Inc
- Ionis Pharmaceuticals Inc
- Regeneron Pharmaceuticals Inc
- Allegro Ophthalmics LLC
- Hemera Biosciences Inc
- Genzyme Corp
- Astellas Pharma Inc
- Alimera Sciences Inc
- IVERIC bio Inc
- Apellis Pharmaceuticals Inc
